Pascolizumab Biosimilar - Anti-IL-4 Antibody - Low endotoxin, Azide free (A323651)

Recombinant humanized monoclonal antibody to IL-4 for ELISA, FACS, Kinetics (BLI), Kinetics (SPR) and Functional Assay.

Freight Charges
Lead Time
7-10 Business Days
Telephone
+1 (314) 370-6046
Mon - Fri, 8am - 4pm AST
Email
orders@antibodies.com
Name
Pascolizumab Biosimilar - Anti-IL-4 Antibody - Low endotoxin, Azide free
Description
Recombinant humanized monoclonal antibody to IL-4.
Applications
ELISA, FACS, Kinetics (BLI), Kinetics (SPR), Functional Assay
Reactivity
Human
Host
Humanized
Clonality
Monoclonal
Isotype
IgG
Light Chains
kappa
Conjugate

Unconjugated

Purification
Protein A affinity chromatography.
Concentration
Reconstitution dependent.
Molecular Weight
This antibody has a predicted MW of 145.5 kDa.
Purity
> 90% (by SDS-PAGE and SEC-HPLC).
Product Form
Lyophilized
Reconstitution
Reconstitute with 100µl of sterile double-distilled water to bring antibody to 1mg/ml concentration. Gently shake to solubilize completely. Do not vortex!
Formulation
Lyophilized from 25mM Histadine, pH 6.2, with 8% Sucrose and 0.01% Tween80.
Storage
Shipped at 4°C. Lyophilized: Store at -20°C to -80°C. Reconstituted: Aliquot and store at -80°C. Product is stable for one year. Avoid freeze/thaw cycles.
Synonyms
B cell growth factor 1, B cell IgG differentiation factor, B cell stimulatory factor 1 , B-cell stimulatory factor 1, BCGF 1, BCGF1, Binetrakin , BSF 1, BSF-1, BSF1 , IGG1 induction factor, IL 4, IL4, Il4e12, IL4_HUMAN, Interleukin 4, Interleukin 4 variant 2, Interleukin 4, isoform 1, Interleukin-4, Lymphocyte stimulatory factor 1, MGC79402, Pitrakinra
Disclaimer
This product is for research use only. It is not intended for diagnostic or therapeutic use.
Publishing research using Pascolizumab Biosimilar - Anti-IL-4 Antibody - Low endotoxin, Azide free (A323651)? Please let us know so that we can list the citation on this page.

Alternative products to Pascolizumab Biosimilar - Anti-IL-4 Antibody - Low endotoxin, Azide free (A323651)

Top